Why Choose Food Research Lab's FRL as Your Food Product Development (FPD) Consultant and Partner?

There are several options in almost every product area in today’s market, and the difficulty is in coming up with unique items that stand out and connect with customers. Food Research Lab's Food Research Lab (FRL) takes a holistic approach to creating food and beverage products. We define, demographically target, and build effective goods through a sequential process for category selection and comprehension. The client can visit the lab to learn the process. We offer unlimited rounds of revisions to ensure customer satisfaction. The final product prototype, along with the documentation process, including the video (through email), will be shipped to the client, and in case the client is not satisfied with the video, a food technology consultant will visit the place for the product demo at the client’s costs.

What are the different forms that you deliver the Food Product Formulations?

The food industry is witnessing a new form of consumption. Keeping that in mind, we can formulate the products in the form of ready-to-eat, ready-to-drink, ready-to-mix, ready-to-serve, and ready-to-cook food products. We use ingredients that offer an added value to the development and improve its indulgence and sustainability in terms of its functional ingredients, plant-based food dyes, and natural preservatives with a clean label.

What are the sectors Food Research Lab cover?

We cover a wide range of sectors such as soups, sauces and dips, chips, tortillas, dry beverage powder, plant-based products, masalas, puddings, instant mixes and many more.

How is sensory testing been carried out?

Our sensory examination leads to the precise formulation and recipe recommendations. We develop data-driven design models based on sensory research and customer insights. The fact-based design methodology used by Food Research Lab reduces risk and gives our clients market confidence while cutting development time in half. With our dedicated sensory lab facility, our team takes satisfaction in creating and optimizing successful products in the marketplace, generating a favourable return on investment, and developing brand advocates.

EU-approved fruitflow: A functional ingredient

22 Aug

EU-approved fruitflow: A functional ingredient

by admin

in Regulation Updates

Comments

Fruitflow: An EU-approved cardioprotective functional ingredient

Fruitflow is a proprietary ingredient developed and marketed by Provexis, a UK-based biotechnology company.

The company produces and sells a range of dietary supplements and functional food products containing Fruitflow, such as capsules, soft gels, effervescent tablets, and food and beverage formulations.
These products are marketed under various brands, including Vegesorb, Sirco, and Tomat-O-Red. Fruitflow is also used as an ingredient in commercial food and beverage products, such as juices, sports drinks, and snacks.
Fruitflow contains all the soluble bioactive compounds from tomatoes. After its discovery in 1999, several studies and human trials were conducted to determine its efficacy.
The study results revealed that the compounds have a potent anti platelet activity, although they have different mechanisms of action. Since platelet hyperactivity is associated with cardiovascular diseases, anti platelet agents are said to be cardioprotective.

The chemical properties of the components can thus be used as therapeutic agents or functional food ingredients.
Fruitflow is available in two forms Fruitflow 1 and Fruitflow 2. Fruitflow 1 is a syrup made from minimally processed tomatoes, while Fruitflow 2 is available as tablets after the sugar content of the tomatoes is reduced.
A study that compared the anti-platelet activity of Fruitflow and aspirin revealed that they have similar potency.
Fruitflow was approved by the EFSA in 2009 under Article 13 of Regulation (EC) No 1924/2006. The health claim that “water-soluble tomato extract helps maintain normal platelet aggregation, which contributes to healthy blood flow” was approved by the EU Commission based on the findings of the eight human and seven non-human studies [1].